speaker-headshot

Eyal Dassau, PhD
Harvard University, Cambridge, Massachusetts

Dr. Eyal Dassau is the Director of the Biomedical Systems Engineering Research Group and Senior Researcher in Biomedical Engineering in the Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University. He is also Adjunct faculty at the Joslin Diabetes Center, Boston MA and an Adjunct Senior Investigator with the Sansum Diabetes Research Institute, Santa Barbara, CA. He received his B.Sc., M.Sc. and Ph.D. degrees in Chemical Engineering from the Technion Israel Institute of Technology, Haifa, Israel in 1999, 2002 and 2006, respectively. Dr. Dassau’s research is focused on the development of connected care solutions and the design of medically inspired control algorithms for people with type 1 diabetes mellitus. He is the lead developer of several algorithms designed to regulate blood glucose, and is the lead developer of the artificial pancreas system (APS) platform: the first software to allow translation of control design to human clinical studies as well as the first interoperable artificial pancreas system (iAPS): a smartphone app for the artificial pancreas. His work matured from theoretical developments (bench testing) to clinical evaluation in humans to commercial implementation. Dr. Dassau published more than 150 peer-review papers, submitted and has been awarded numerous patents.